These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 25897647)
1. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Van De Wier B; Koek GH; Bast A; Haenen GR Crit Rev Food Sci Nutr; 2017 Mar; 57(4):834-855. PubMed ID: 25897647 [TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422 [TBL] [Abstract][Full Text] [Related]
3. Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy. Pisonero-Vaquero S; González-Gallego J; Sánchez-Campos S; García-Mediavilla MV Curr Med Chem; 2015; 22(25):2991-3012. PubMed ID: 26242257 [TBL] [Abstract][Full Text] [Related]
9. The great potential of flavonoids as candidate drugs for NAFLD. Li L; Qin Y; Xin X; Wang S; Liu Z; Feng X Biomed Pharmacother; 2023 Aug; 164():114991. PubMed ID: 37302319 [TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease and flavonoids: Current perspectives. Shin JH; Jung JH Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):17-24. PubMed ID: 27545758 [TBL] [Abstract][Full Text] [Related]
12. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease. Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185 [TBL] [Abstract][Full Text] [Related]
13. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529 [TBL] [Abstract][Full Text] [Related]
14. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. Chen G; Ni Y; Nagata N; Xu L; Ota T Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875 [TBL] [Abstract][Full Text] [Related]
15. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Sugimoto K; Inui H; Fukusato T World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263 [TBL] [Abstract][Full Text] [Related]
16. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease. Liu Q; Zhu L; Cheng C; Hu YY; Feng Q Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892 [TBL] [Abstract][Full Text] [Related]
17. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. Yan Z; Miao X; Zhang B; Xie J Life Sci; 2018 Dec; 215():64-72. PubMed ID: 30473026 [TBL] [Abstract][Full Text] [Related]
18. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892 [TBL] [Abstract][Full Text] [Related]
19. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver. Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520 [TBL] [Abstract][Full Text] [Related]
20. New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. Wang K; Tan W; Liu X; Deng L; Huang L; Wang X; Gao X Biomed Pharmacother; 2021 May; 137():111326. PubMed ID: 33556870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]